New publication shows Cognition Kit DSST app-based assessment is highly correlated with traditional paper-and-pencil tests and points way to the test's potential use to inform care, psychotherapeutic and pharmacologic treatment decisions for MDD.
mental.jmir.org/2022/10/e338…
4 years after starting this project, our paper is now in JMIR "Wearable Technology for High-Frequency Cognitive and Mood Assessment in Major Depressive Disorder: Longitudinal Observational Study". Congrats to the team! 🎉@ctrl_group@cognitionkit@CANTABconnect!
JMIR Mental Health: Wearable Technology for High-Frequency Cognitive and Mood Assessment in Major #depressive Disorder: Longitudinal Observational Study dlvr.it/RJXTSN
Will we see you at #APAAM18 this weekend?
Join innovation experts, Dr Francesca Cormack and @BenFehnert, in New York to discuss how technology can enhance patient engagement.
ow.ly/uh8D30jOK6i
.@advocatehealth and @TakedaPharma's advice for a successful collaboration: Identify common goals and values, create a team of key champions & communicate with transparency. #healthtogether
Engagement & support is a key component of providing excellent care to patients with Major Depressive Disorder (MDD). @TakedaPharma, @advocatehealth & @LundbeckUS teamed up to research the effectiveness of a mobile app to improve engagement between MDD patients and their doctors.
Shocking @guardian report that 'Poor communication between staff or agencies' were noted in 112 of the analysed UK deaths of 271 mental health patients. Surely a case for more analysis of mental health management & opportunities #MEDTECH & #userresearchtheguardian.com/society/2018…
Thanks so much for the hospitality from @TakedaPharma in Deerfield, Illinois, US over the last few days and all the discussion around helping patients #mentalhealth through improved #PatientExperience using #MEDTECH